Use of Biosynthetic Controls as Performance Standards for Next-Generation Sequencing Assays of Somatic Tumors: A Multilaboratory Study.
暂无分享,去创建一个
Bharathi Anekella | Helen Fernandes | Andrea Ferreira-Gonzalez | Francine B De Abreu | Jason D Peterson | Sophie J Deharvengt | Robert Daber | Vishal K Sarsani | Vanessa Spotlow | Robin D Harrington | Chih-Jian Lih | P Mickey Williams | Courtney H Bouk | Yves Konigshofer | Catherine Huang | Lorn Davis | Russell K Garlick | Catherine I Dumur | Stephen Haralampu | Gregory J Tsongalis | P. M. Williams | C. Lih | S. Haralampu | V. Sarsani | G. Tsongalis | Courtney H. Bouk | C. Dumur | R. Daber | A. Ferreira-Gonzalez | S. Deharvengt | H. Fernandes | Jason D. Peterson | Yves Konigshofer | R. Garlick | F. D. De Abreu | Catherine Huang | V. Spotlow | R. Harrington | B. Anekella | L. Davis
[1] Birgit Funke,et al. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. , 2015, Archives of pathology & laboratory medicine.
[2] Robin D Harrington,et al. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays. , 2016, The Journal of molecular diagnostics : JMD.
[3] Andrea Ferreira-Gonzalez,et al. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing , 2015, Diagnostic Pathology.
[4] W. Kochen,et al. Tryptophan-Stoffwechseluntersuchungen bei unbehandelten Phenylketonurikern , 1975 .
[5] Joshua L. Deignan,et al. ACMG clinical laboratory standards for next-generation sequencing , 2013, Genetics in Medicine.
[6] R. Luthra,et al. Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges , 2015, Cancers.
[7] David J. Sims,et al. Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. , 2016, The Journal of molecular diagnostics : JMD.
[8] C. Amos,et al. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations , 2014, Clinical chemistry and laboratory medicine.
[9] Paul D. Williams,et al. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors12 , 2015, Neoplasia.
[10] Shashikant Kulkarni,et al. Assuring the quality of next-generation sequencing in clinical laboratory practice , 2012, Nature Biotechnology.
[11] Eric Samorodnitsky,et al. Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing , 2015, Human mutation.
[12] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[13] Philip Hugenholtz,et al. Shining a Light on Dark Sequencing: Characterising Errors in Ion Torrent PGM Data , 2013, PLoS Comput. Biol..
[14] C. Amos,et al. Effective quality management practices in routine clinical next-generation sequencing , 2016, Clinical chemistry and laboratory medicine.